http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010123003-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
filingDate 2008-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2010123003-A
titleOfInvention METHODS FOR PRODUCING AND INTERMEDIATE COMPOUNDS FOR PRODUCING AMINOBENZYMIDAZOLMETA
abstract 1. The method of obtaining 1-ethyl-3- (5- (5-fluoropyridin-3-yl) -7- (pyrimidin-2-yl) -1H-benzo [d] imidazol-2-yl) urea of the formula 1:! ! including! i) the provision of 3-fluoro-5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) pyridine (formula 2) and 4-bromo-2-nitro-6- (pyrimidine -2-yl) benzeneamine (formula 3),! ! ii) the cross-combination of the compounds of formula 2 and the compounds of formula 3 in a two-phase mixture containing water, an organic solvent, a base and a transition metal catalyst to obtain 4- (5-fluoropyridin-3-yl) -2-nitro-6- (pyrimidine- 2-yl) benzeneamine of the formula 4,! ! iii) reduction of a compound of formula 4 to obtain 5- (5-fluoropyridin-3-yl) -3- (pyrimidin-2-yl) benzene-1,2-diamine of formula 5,! ! iv) reacting a compound of formula 5 with a compound of formula 6,! ! in a two-phase mixture containing buffer water and an organic solvent to obtain a compound of formula 1.! 2. The method according to claim 1, in which the organic solvent in item ii) is an aprotic solvent. ! 3. The method according to claim 2, wherein said aprotic solvent is 1,2-dimethoxyethane or dioxane. ! 4. The method according to claim 1, in which the base according to ii) is an inorganic base. ! 5. The method according to claim 4, in which the specified inorganic base is selected from potassium carbonate, cesium carbonate and potassium phosphate. ! 6. The method according to claim 1, in which the transition metal catalyst according to item ii) is a palladium based catalyst. ! 7. The method according to claim 6, in which the palladium-based catalyst is palladium (II) acetate, tetrakis (triphenylphosphine) palladium (0) or tris (dibenzylideneacetone) dipalladium (0). ! 8. The method according to claim 1, wherein the biphasic mixture indicated in paragraph ii) further comprises a phosphine ligand. ! 9. The method according to claim 8, in k�
priorityDate 2007-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451127074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457773519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11494578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450737290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410506103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424421238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67004766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422153089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426226509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450766143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16414268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50912043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448769888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11979704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406970473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425546795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420215980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9811564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454250970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1100
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57738060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448347448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407907394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424295082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450723585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57738059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410932322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407378349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57566645

Total number of triples: 75.